Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Jun 2025 for Corvus Pharmaceuticals, Inc., €59k. Read the official filing
Filing timeline
BuySaleWilliam Benton Jones
Insider track record
Disclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+69.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
William Benton Jones: trading record in brief
William Benton Jones is a declared insider of Corvus Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 20 December 2022 to 4 June 2025, the count stands at 3 filings.
The open-market record is one-sided, with 2 purchases worth €47k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 option exercise.
Most recently, on 6 June 2025, the filings show an option exercise worth €59k in Corvus Pharmaceuticals, Inc. The last purchase on record was published on 7 May 2024, which is 894 days ago. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to William Benton Jones
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
19,357 shares@ US$3.50Common StockSEC:0001610717-25-000174:0
20,000 shares@ US$1.731268.4% of flowCommon StockSEC:0001610717-24-000232:0
Canonical exit: 4 Aug 2024 (T+90)
20,000 shares@ US$0.7931.6% of flowCommon StockSEC:0001567619-22-021876:0
Canonical exit: 20 Mar 2023 (T+90)
3 of 3 declarations
